Company & Sponsor Intelligence
University of Minnesota
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials2
Recruiting1
Completed1
Countries1
Therapeutic footprint
alzheimersparkinsons
Indexed studies
NCT01100658Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors
adhd · United StatesNA
adhd · United StatesNA
NCT04700540A Mobile Informatics Solution to Aid in Memory
alzheimers · United StatesNA
alzheimers · United StatesNA
NCT05557864Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT02002819Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability
alzheimers · United StatesPHASE2
alzheimers · United StatesPHASE2
Intelligence layer updated: 2026-06-10 02:57:56.223123+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →